Literature DB >> 3325681

Modulation of brain acetylcholine levels with cholinesterase inhibitors as a treatment of Alzheimer disease.

E Giacobini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3325681     DOI： 10.2302/kjm.36.381

Source DB:  PubMed          Journal:  Keio J Med        ISSN： 0022-9717


× No keyword cloud information.
  5 in total

1.  Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.

Authors:  V C Hinz; S Grewig; B H Schmidt
Journal:  Neurochem Res       Date:  1996-03       Impact factor: 3.996

Review 2.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

3.  Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats.

Authors:  V C Hinz; J Kolb; B H Schmidt
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

4.  Alzheimer's disease: is a vaccine possible?

Authors:  R P S Alves; M J Yang; M T Batista; L C S Ferreira
Journal:  Braz J Med Biol Res       Date:  2014-06-03       Impact factor: 2.590

Review 5.  New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.

Authors:  Marco T Nuñez; Pedro Chana-Cuevas
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.